Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ELVN Hot Sheet
Join SI Premium – FREE
Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.48), $0.02 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
- ReconAfrica launches C$15M bought-deal offering for drilling program
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
